SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Strides Pharma Science informs about newspaper publication

04 Sep 2018 Evaluate

In reference to company’s intimation letter dated August 31, 2018 relating to Notice of 27th Annual General Meeting and Book Closure intimation. In compliance with Regulation 30 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, Strides Pharma Science has informed about copies of newspaper advertisements confirming completion of dispatch of notices to the eligible members of the Company as published in Business Standard (English Edition) and in Navshakti (Marathi Edition).

The above information is a part of company’s filings submitted to BSE.

Strides Pharma Scien Share Price

1081.80 7.95 (0.74%)
10-Jul-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1935.25
Dr. Reddys Labs. 1245.50
Cipla 1438.75
Zydus Lifesciences 1150.50
Lupin 2496.05
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: